Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

Brand drugFirst approved 2002

Abilify(Aripiprazole)Otsuka Holdings Co., Ltd. logo4578.T

Medicare prescription drug cost, prescriptions and prescribers, 2024 · made by Otsuka Holdings Co., Ltd.

$7.1M

Medicare cost, 2024

Medicare drug plans spent $7.1 million on Abilify (aripiprazole) in 2024, for 7,131 prescriptions and refills filled by 1,478 patients. Spending fell 40% from 2023 to 2024. New York accounts for the most spending ($1.0 million, 15% of the total). It is made by Otsuka Holdings Co., Ltd. (4578.T).

Medicare cost, 2024

$7.1M

-40.5% from 2023

Prescriptions

7,131

$990.97 per claim

Patients

1,478

1,715 prescribers

Total spending, 2024

$7.1M

$4,780.60 per patient

Questions and answers

How much does Medicare spend on Abilify?

Medicare prescription drug plans paid $7.1M for Abilify in 2024, for 7,131 prescriptions and refills to 1,478 patients (down 40.5% from 2023). The average cost per claim was $990.97.

Which state spends the most on Abilify?

New York had the highest Medicare cost for Abilify in 2024: $1.0M for 1,102 claims, followed by California ($896K).

Who prescribes Abilify the most?

Sophia A Francis Stewart, psychiatry & neurology in Baldwin, NY, had the highest Medicare cost for Abilify in 2024: 37 claims costing $46K.

Who makes Abilify?

Abilify is made by Otsuka Holdings Co., Ltd. (4578.T), listed in the Medicare spending data as Otsuka America.

Spending over the years

Medicare spending by year

All plans and makers

Prescriber data: cost by year

Medicare spending on Abilify was $7.1M in 2024, after a high of $24.5M in 2020.

By state

Where the prescribers practice, 2024

Medicare cost by state

States with the highest cost

Top prescribers of Abilify, 2024

By Medicare drug cost

PrescriberTypeClaimsPatientsCost
Sophia A Francis Stewart Baldwin, NYPsychiatry & Neurology37Under 11$46K
Paul A Zarkowski Seattle, WAPsychiatry39Under 11$42K
Margaret M Briese Saint Peter, MNCertified Clinical Nurse Specialist30Under 11$37K
James E Townsend East Setauket, NYPsychiatry25Under 11$35K
Jeffrey A Coffman Lincoln, NEPsychiatry17Under 11$28K
1710920111 Psychiatry & Neurology26Under 11$26K
Michael N Rubenstein Meadowbrook, PANeurology12Under 11$26K
James E Owens III Salina, KSPsychiatry16Under 11$25K
Elston L Volkerts White Plains, NYNurse Practitioner25Under 11$24K
Deborah Pfeffer Woodbury, NYPsychiatry17Under 11$23K
Jasmine J Hohl Salt Lake City, UTPhysician Assistant13Under 11$22K
Michelle M Malloy Belle Plaine, IANurse Practitioner12Under 11$22K
Tara Lovings Bronx, NYPsychiatry28Under 11$22K
Mark J Hauser Newton, MANeuropsychiatry12Under 11$21K
Holly Vause Denver, CONurse Practitioner13Under 11$21K
David J Posey Indianapolis, INNeuropsychiatry19Under 11$20K
Inessa Meyerovich Rego Park, NYPsychiatry27Under 11$20K
Andrew A Nierenberg Boston, MAPsychiatry12Under 11$20K
Isak Isakov Forest Hills, NYPsychiatry29Under 11$19K
Richard A Glass Jr. Greenbrae, CAPsychiatry12Under 11$18K
Roxana G Llovet Bridgeport, CTPsychiatry12Under 11$18K
Jessica L Flowers Lexington, MANurse Practitioner16Under 11$18K
Giovanny M Nunez New York, NYPsychiatry25Under 11$16K
Raja M Akbar Waterloo, IAPsychiatry22Under 11$16K
Albert C Lo Bryan, TXPsychiatry17Under 11$15K

Prescriber data by year

YearPrescribersClaimsPatientsCost
20222,26513,5691,918$13.1M
20232,11112,0961,734$11.9M
20241,7157,1311,478$7.1M

Makers, 2024

Spending by manufacturer as listed in the spending data

ManufacturerClaimsSpending
Otsuka America4578.T logo4578.T7,139$7.1M

Medicaid spending by quarter

Amount reimbursed by state Medicaid programs, all states

Amount reimbursed

Codes

National drug codes (packages)
15
RxNorm concept IDs
349490, 349545, 349547, 349553, 352307
Application numbers
NDA021436

More drugs: Medicare drug spending and the Prescriptions view.

Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.

LinkedInLinkedInXXYouTubeYouTube